QUANTALX NEUROSCIENCE LTD

General Data

supplementary funding
Reg Number
515049260
Sector
Digital Health
Established
2014
No. of Employees
20
Stage
R&D
Additional Funding
1

Description

Delphi-MD is a first-in-class device providing functional visualization and quantitative analysis for the early detection and differential diagnosis of brain disorders

Technology

QuantalX is a developer of a brain imaging technology, designed to provide insights into human brain function. The company uses a patient-independent active cerebral function imaging system that delivers a visual map of brain network health and is non-invasive, radiation-free and easy to use, enabling physicians and medical professionals to devise an optimal personalized treatment plan.

Targeted Customers

Sufferers of Brain Disorders, Neurologists, Healthcare Technicians.

Management personnel

Iftach Dolev - CEO & Co-Founder
Hilla Fogel - CTO & Co-Founder
Aviram Arviv - CFO

Contact information

Name
Website
https://www.quantalx.com
Country
United States
Zip
10007

Tags

BrainTechDiagnosticsDigital HealthHealthtechLife SciencesManaged CareMedTechMental HealthNeurologyNeuroscienceRisk Assessment

Classified Technologies

Biomedicine and pharmaceuticals

Winning details

Route name
Winning year

The Expedited Program
The Expedited Program
2024